{"schema_version":"secwatch.filing_event.v1","accession":"0001585364-26-000035","form_type":"8-K","ticker":"PRGO","cik":"0001585364","company_name":"PERRIGO Co plc","filed_at":"2026-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.522997+00:00","generated_at":"2026-05-15T04:53:48.875411+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Perrigo revises segment reporting; FY2025 includes $1.36B impairment charge","bullets":["Self Care segment net sales $2,533.5M in FY2025, down from $2,554.3M in FY2024.","Infant Formula segment net sales $359.0M in FY2025, down from $397.0M in FY2024.","Adjusted operating income for segments totaled $682.6M in FY2025, consolidated adjusted operating income $622.3M.","Q4 2025 goodwill impairment of $1.3B plus $33.6M equity method impairment contributed to reported operating loss of $1,122.2M.","Segment change effective Q1 2026; recast historical data provided for comparability."],"urls":{"canonical":"https://secwatch.observer/filing/0001585364-26-000035","json":"https://secwatch.observer/filing/0001585364-26-000035.json","markdown":"https://secwatch.observer/filing/0001585364-26-000035.md","text":"https://secwatch.observer/filing/0001585364-26-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585364/000158536426000035/0001585364-26-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585364/000158536426000035/prgo-20260422.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:53:48.875411+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}